Patents/Assignees

ONCOBIX CO., Ltd.

1 patent in portfolio

US12421221utility2025
Heterocyclic-substituted Pyrimidine Derivative Exhibiting Cancer Cell Growth Inhibitory Effect, and Pharmaceutical Composition Containing Same
0 cites